APO-FAMCICLOVIR 250 MG
FAMCICLOVIR : 250 MG · DIN 02292041 · APOTEX INC
Health Canada status: MARKETED
What is APO-FAMCICLOVIR?
APO-FAMCICLOVIR 250 MG contains FAMCICLOVIR : 250 MG. It is listed in the Health Canada Drug Product Database under DIN 02292041, held by APOTEX INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 22-Feb-2007. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is APO-FAMCICLOVIR used for?
Treatment of acute herpes zoster (shingles); treatment/suppression of recurrent genital herpes in immunocompetent adults; recurrent mucocutaneous herpes simplex in HIV-infected patients.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02292041 |
|---|---|
| Brand name | APO-FAMCICLOVIR |
| Generic / active ingredient | FAMCICLOVIR : 250 MG |
| Manufacturer | APOTEX INC |
| Strength | 250 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AB09 FAMCICLOVIR |
| AHFS class | 08:18.32 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 22-Feb-2007 |
| Original market date | 2007-02-22 00:00:00 |
How is it administered?
Herpes zoster: 500 mg tid for 7 days. Genital herpes: 125 mg bid for 5 days (recurrent) or 250 mg bid for up to 1 year (suppression). HIV-infected: 500 mg bid for 7 days. Requires renal adjustment.
Included because it drives pack selection and wastage. Consult the monograph.
How is it stored and handled?
Store at controlled room temperature (between 15°C and 30°C).
How is it supplied?
125 mg and 250 mg: Bottles of 30 and 500 tablets. 500 mg: Bottles of 30 and 500 tablets.
Contraindications
Known hypersensitivity to APO-FAMCICLOVIR or to any ingredient in the formulation or component of the container.
Warnings and precautions
Dosage adjustment required in renal dysfunction. Efficacy not established for first episode genital herpes or disseminated zoster. May cause dizziness/confusion; caution when driving.
What can be used instead?
Other Canadian products sharing ATC code J05AB09 FAMCICLOVIR. 6 of 36 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-FAMCICLOVIR | 125 MG | TABLET | APOTEX INC | MARKETED | DIN 02292025 |
| APO-FAMCICLOVIR | 500 MG | TABLET | APOTEX INC | MARKETED | DIN 02292068 |
| FAMVIR | 125 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02229110 |
| FAMVIR | 250 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02229129 |
| FAMVIR | 500 MG | TABLET | SEARCHLIGHT PHARMA INC | MARKETED | DIN 02177102 |
| ACT FAMCICLOVIR | 125 MG | TABLET | TEVA CANADA LIMITED | DORMANT | DIN 02305682 |
| ACT FAMCICLOVIR | 250 MG | TABLET | TEVA CANADA LIMITED | DORMANT | DIN 02305690 |
| ACT FAMCICLOVIR | 500 MG | TABLET | TEVA CANADA LIMITED | DORMANT | DIN 02305704 |
| AURO-FAMCICLOVIR | 125 MG | TABLET | AURO PHARMA INC | APPROVED | DIN 02431564 |
| AURO-FAMCICLOVIR | 250 MG | TABLET | AURO PHARMA INC | APPROVED | DIN 02431572 |
Who else supplies FAMCICLOVIR worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. FAMCICLOVIR appears in 157 registered pack listings across 11 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.